一种新型的氧化捐赠体NONO2P,通过NO/sGC/PKG通路引起血管松,K道开放和SERCA激活
Raiana A Moraes1, Daniele S Brito1, Fênix A Araujo1
1Laboratory of Cardiovascular Physiology and Pharmacology, Bioregulation Department, Federal University of Bahia, UFBA, Salvador, Bahia, Brazil; Gonçalo Moniz Institute, FIOCRUZ, Salvador, BA, Brazil.
作为一种新型的氧化 (NO) 供体,NONO2P通过释放NO基和离子有效地放松中枢动脉. 它的作用涉及可溶性瓜尼利基环酶,蛋白激酶G和离子通道,表明对心血管疾病的治疗潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心血管生理学心血管生理学
- 分子生物学分子生物学
背景情况:
- 心血管疾病 (CVD) 治疗可以通过氧化 (NO) 捐赠者来改善.
- NONO2P 是一种潜在的治疗心血管疾病的药物.
研究的目的:
- 为了研究NONO2P在中枢动脉中的作用机制.
- 为了比较NONO2P的药理作用与酸 (SNP) 和NO.
主要方法:
- 在老鼠上层中枢动脉中的同位数张力记录.
- 测量NO和循环瓜诺辛单酸盐 (cGMP) 的水平.
- 药理上抑制NO通路,离子通道和处理.
主要成果:
- 在诱导血管扩张方面,NONO2P表现出类似于SNP的疗效.
- NONO2P会释放NO基 (NO•) 和氧离子 (NO−).
- 血管扩张涉及可溶性瓜尼利基环酶 (sGC),cGMP依赖蛋白激酶 (PKG),K+通道 (Kir,KV,BKCa) 和SERCA激活.
结论:
- 通过NO•和NO−释放,NONO2P诱导血管扩张,通过sGC,PKG,K+通道和SERCA起作用.
- NONO2P的机制表明,它对心血管疾病有潜在的治疗应用.
更多相关视频
08:23Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
09:47Measurement of Endothelium-Dependent Vasorelaxation in the Mouse Thoracic Aorta Using Tensometric Small Volume Chamber Myography
Published on: August 12, 2022
相关概念视频
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Vasodilators
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Paracrine Signaling
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
